ACADIAN ASSET MANAGEMENT LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 52 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$52,000
+126.1%
2,025
+97.0%
0.00%
Q4 2020$23,000
-75.8%
1,028
-76.3%
0.00%
Q4 2019$95,000
-57.8%
4,334
-81.6%
0.00%
-100.0%
Q1 2018$225,000
+22400.0%
23,566
+7151.1%
0.00%
Q1 2017$1,000
-92.3%
325
-66.3%
0.00%
Q2 2015$13,0009640.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders